All that mess might be true except for the one variable you really don't know. And that is a buyout. It comes swiftly and generally unannounced - like grim death. Good luck getting in at this price if and when that happens. You really don't know what's going to happen. I'm putting you on ignore. Invest in Rosetta Stone for English. That's where you need to put your money.
I'd like to preface my answer by saying that I have held this stock a long time; it made me a lot of money. However, although the future looks brighter than the past months (or years) I would have to stay I believe it is slightly less than 50% chance of advancing to 600 this month for a couple of reasons. First, they still face significant challenges in China because of the issues with prices and the lack of subsidies. Please correct me if I'm wrong, but I also understand that China is not using 4G, so that is yet another issues Apple will have to challenge. Lastly, the Fed may be tapering bond buying soon, which may make cautious investors skiddish and pull money out of the market. I believe that Apple will reach $600 again - and exceed that level. I don't think it's a solid bet this month. That being said - I hope that I'm mistaken. GLTA
LOL! NO. Totally different animal. Your rhetoric needs work.
The short trade on this would have to be pretty tight. Scary tight. Besides, there is a lot to lose when the next catalyst plays out...
You're barking up the wrong tree, anal. You should head over to the VTUS board and get something for that nasty sore.
I'm thinking there must be computer programs initiating sells on these events because I can't imagine any rational person selling when we could be days - or even hours away from a bigger payoff.
Sentiment: Strong Buy
Not sure where you're getting your numbers, but I see 42M total shares outstanding wtih only about 20M in the float. The shares short are up slightly, but it's still under 20%. I may be wrong, but it's not likely.
Folks may be anticipating the acceptance due near the end of November. Hopefully we'll have one more thing to be thankful for this Thanksgiving.
That's exactly my predicament. i bought in at $31 and out at $52. I need to look at the chart to figure a new entry point, but ya, it would be silly not go get back in IMHO. The sky's the limit for this technology, and DDD seems to be grass roots.
We'll at least get a double out of both of them; the sources that be might say that's conservative. I'd suggest you take a look at the Web sites. These boards are a good starting point and place for discussion, but really, by no means for checking the Web sites and contacting the company directly. Personally, I don't stick my neck out unless A) they have a product with a competitive advantage/first starter (something that addresses a need not already addressed by other or few substandard products). B) They have several products in the pipeline, and C) Management team needs to be proven. But that's me.
I agree completely. I was watching from the sidelines and never bought in, as I was real skiddish of that reverse split. But this could happen to any of us trading bio-techs. It's heartbreaking to think of people losing their life savings. I don't know how some people can be so heartless as to feel otherwise. For those of you who got caught in this mess, I know you will have better days ahead.
I have a large portion of my speculative portfolio in ACRX and VTUS. Please, do your own DD on these. In my opinion they are pretty solid. ACRX should pop in 2014 - it has several promising drugs in the pipeline, and the management team is stellar. VTUS has a medication specific to a particular medical issue not currently addressed by other medications (anal fissures). I would also consider the 3-D copier sector (DDD, SSYS, and XONE). But do your homework. Good luck.
That's terrific Miss Kitty! I'm so happy for you! I'd like to also send out thanks to you (and the Beav) for your excellent information and advice on these boards. I've been following along since TSRX! You definitely have earned to good Karma!